AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 63 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 6.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 10,000 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -75.0% | 10,000 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $4,000 | -20.0% | 10,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $5,000 | -68.8% | 10,000 | 0.0% | 0.00% | -60.0% |
Q3 2021 | $16,000 | 0.0% | 10,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $16,000 | 0.0% | 10,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $16,000 | +6.7% | 10,000 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $15,000 | +66.7% | 10,000 | 0.0% | 0.01% | +25.0% |
Q3 2020 | $9,000 | +50.0% | 10,000 | 0.0% | 0.00% | +33.3% |
Q2 2020 | $6,000 | +50.0% | 10,000 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $4,000 | -20.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $5,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $5,000 | +66.7% | 10,000 | 0.0% | 0.00% | +100.0% |
Q2 2019 | $3,000 | -40.0% | 10,000 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $5,000 | +66.7% | 10,000 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $3,000 | -40.0% | 10,000 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $5,000 | -77.3% | 10,000 | 0.0% | 0.00% | -75.0% |
Q2 2018 | $22,000 | -35.3% | 10,000 | 0.0% | 0.01% | -33.3% |
Q1 2018 | $34,000 | -15.0% | 10,000 | 0.0% | 0.01% | -20.0% |
Q4 2017 | $40,000 | +566.7% | 10,000 | 0.0% | 0.02% | +650.0% |
Q3 2017 | $6,000 | +20.0% | 10,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $5,000 | -37.5% | 10,000 | 0.0% | 0.00% | -33.3% |
Q1 2017 | $8,000 | -11.1% | 10,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $9,000 | +28.6% | 10,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $7,000 | -41.7% | 10,000 | 0.0% | 0.00% | -40.0% |
Q2 2016 | $12,000 | -45.5% | 10,000 | 0.0% | 0.01% | -44.4% |
Q1 2016 | $22,000 | -37.1% | 10,000 | 0.0% | 0.01% | -35.7% |
Q4 2015 | $35,000 | +25.0% | 10,000 | 0.0% | 0.01% | +16.7% |
Q3 2015 | $28,000 | +21.7% | 10,000 | 0.0% | 0.01% | +50.0% |
Q2 2015 | $23,000 | -69.3% | 10,000 | 0.0% | 0.01% | -70.4% |
Q1 2015 | $75,000 | +120.6% | 10,000 | 0.0% | 0.03% | +125.0% |
Q4 2014 | $34,000 | -2.9% | 10,000 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $35,000 | -57.8% | 10,000 | 0.0% | 0.01% | -57.1% |
Q2 2014 | $83,000 | +31.7% | 10,000 | 0.0% | 0.03% | +21.7% |
Q1 2014 | $63,000 | -11.3% | 10,000 | 0.0% | 0.02% | -14.8% |
Q4 2013 | $71,000 | -5.3% | 10,000 | 0.0% | 0.03% | -12.9% |
Q3 2013 | $75,000 | – | 10,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |